Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-001690-28Phase 4Completed
Phase 4, randomised, double-blind trial of testosterone in Hypogonadism and cardiometabolic risk (CMR) (3 arms), sponsored by University Hospital Odense. Primary endpoint: Lean Body Mass. Started Jun 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-001690-28.